# Influence of Rivaroxaban for Intermittent Claudication and Exercise Tolerance in Patients With Symptomatic PAD

> **NCT04305028** · — · UNKNOWN · sponsor: **Poznan University of Medical Sciences** · enrollment: 100 (estimated)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DRUG:** Rivaroxaban
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT04305028
- **Lead sponsor:** Poznan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-10
- **Primary completion:** 2021-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04305028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04305028, "Influence of Rivaroxaban for Intermittent Claudication and Exercise Tolerance in Patients With Symptomatic PAD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04305028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*